K

Kurome Therapeutics, Inc.

8 employees

Kurome Therapeutics is a preclinical stage company focused on subverting cancer's ability to evade therapy.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
structure-based drug design
therapeutics
biomarkers
drug development
oncology
diagnostics
Health Care
FLT3 inhibitors
Therapeutics
cancer
IRAK inhibitors
start-up

Date founded

2019

Funding rounds raised

Total raised

$15M

from 5 investors over 5 rounds

K

Kurome Therapeutics, Inc. raised $15M on June 10, 2021

Investors: Queen City Angels, Medicxi, CincyTech USA and Affinity Asset Advisors

K

Kurome Therapeutics, Inc. raised undisclosed on April 29, 2020

Investors: CincyTech USA

FAQ